Screening of Nattokinase Producing Strain and Characterazation of Nattokinase

doi:10.13560/j.cnki.biotech.bull.1985.2015.04.023

Abstract

Abstract: To develop new kinds of natto health care products with specific physiological activity, a nattokinase high-yield strain was isolated and used for natto production. The characteristics and nattokinase activities of the isolated strain were compared with other 3 kinds of natto strains. Results showed that the natto products of munber 5 strain have golden color and soy sauce flavor, and have the best length of natto wire drawing. The result of fermentation time showed that nattokinase content reached the maximum value at 17 h.

Key words: nattokinase, screen, enzyme activity, characteristic

Zhao Zhonglin, Li Shuying, Nie Ying, Li Yan, Yuan Chao, Tang Xuanming. Screening of Nattokinase Producing Strain and Characterazation of Nattokinase[J]. Biotechnology Bulletin, 2015, 31(3): 161-164.

References

[1] Tai MW, Sweet BV. Nattokinase for prevention of thrombosis[J]. Am J Health Syst Pharm, 2006, 63(12)：1121-1123.
[2] Fujita M, Ohnishi K, Takaoka S. Antihypertensive effects of continuous oral administration of nattokinase and its fragments in spontaneously hypertensive rats[J]. Biol Pharm Bull, 2011, 34(11)1696-1701.
[3] Jang JY, Kim TS, Cai J, et al. Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation[J]. Lab Anim Res, 2013, 29(4)：221-225.
[4] Xu J, Du M, Yang X, et al. Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis[J]. Acta Haematol, 2014, 132(2)：247-253.
[5] Urano T, Ihara H, Umemura K, et al. The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1[J]. J Biol Chem, 2001, 276：24690-24696.
[6] Jovin IS, Muller BG. Inter-relationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis[J]. Atherosclerosis, 2004, 174：225-233.
[7] Ero MP, Ng CM, Mihailovski T, et al. A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose[J]. Altern Ther Health Med, 2013, 19(3)：16-19.
[8] Fadl NN, Ahmed HH, et al. Sayed AH. Serrapeptase and nattokinase intervention for relieving Alzheimer’s disease pathophysiology in rat model[J]. Hum Exp Toxicol, 2013, 32(7)：721-735.
[9] 李淑英, 赵仲麟, 聂莹, 等. 纳豆激酶研究进展[J]. 中国农业科技导报, 2013, 15(4)：139-143.
[10] Astrup T, Mullertz S. The fibrin plate method for estimating fibrinolytic activity[J]. Arch Biochem Biophys, 1952, 40(2)：346-351.
[11] 马明, 杜金华, 于玲, 等. 高纳豆激酶酶活枯草芽孢杆菌的筛选及菌种鉴定[J]. 中国食物与营养, 2006(8)：29-32.
[12] 李淑英, 聂莹, 杜欢, 等. 纳豆激酶生产菌BSNK-5鉴定及发酵条件优化[J]. 生物技术通报, 2013(2)：184-189.
[13] Nguyen TT, Quyen TD, Le HT. Cloning and enhancing production of a detergent- and organic-solvent-resistant nattokinase from Bacillus subtilis VTCC-DVN-12-01 by using an eight-protease-gene-deficient Bacillus subtilis WB800[J]. Microb Cell Fact, 2013, 12：79.
[14] Wei XT, Luo MF, et al. Strain Screening, fermentation, separation, and encapsulation for production of nattokinase functional food[J]. Appl Biochem Biotechnol, 2012, 168：1753-1764.
[15] Dong XY, Kong FP, Yuan GY, et al. Optimisation of preparation conditions and properties of phytosterol liposome-encapsulating nattokinase[J]. Nat Prod Res, 2012, 26(6)：548-556.